Department of Chemistry and Biochemistry, University of Delaware, Newark, DE, 19716, USA.
Dalton Trans. 2023 Jun 6;52(22):7512-7523. doi: 10.1039/d3dt00691c.
Photodynamic therapy (PDT) is a promising treatment for certain cancers that proceeds sensitization of ground state O to generate reactive O. Classic macrocyclic tetrapyrrole ligand scaffolds, such as porphyrins and phthalocyanines, have been studied in detail for their O photosensitization capabilities. Despite their compelling photophysics, these systems have been limited in PDT applications because of adverse biological side effects. Conversely, the development of oligotetrapyrrole ligands metalated with palladium (Pd[DMBil1]) have established new candidates for PDT that display excellent biocompatibility. Herein, the synthesis, electrochemical, and photophysical characterization of a new family of 2,18-bis(phenylalkynyl)-substituted Pd 10,10-dimethyl-5,15-bis(pentafluorophenyl)-biladiene (Pd[DMBil2-R]) complexes is presented. These second generation biladienes feature extended conjugation relative to previously characterized Pd biladiene scaffolds (Pd[DMBil1]). We show that these new derivatives can be prepared in good yield and, that the electronic nature of the phenylalkynyl appendages dramatically influence the Pd biladiene photophysics. Extending the conjugation of the Pd[DMBil1] core through installation of phenylacetylene resulted in a ∼75 nm red-shift of the biladiene absorption spectrum into the phototherapeutic window (600-900 nm), while maintaining the Pd biladiene's steady-state spectroscopic O sensitization characteristics. Varying the electronics of the phenylalkyne groups installation of electron donating or withdrawing groups dramatically influences the steady-state spectroscopic and photophysical properties of the resulting Pd[DMBil2-R] family of complexes. The most electron rich variants (Pd[DMBil2-N(CH3)2]) can absorb light as far red as ∼700 nm but suffer from significantly reduced ability to sensitize formation of O. By contrast, Pd[DMBil2-R] derivatives bearing electron withdrawing functionalities (Pd[DMBil2-CN] and Pd[DMBil2-CF3]) display O quantum yields above 90%. The collection of results we report suggest that excited state charge transfer from more electron-rich phenyl-alkyne appendages to the electron deficient biladiene core circumvents triplet sensitization. The spectral and redox properties, as well as the triplet sensitization efficiency of each Pd[DMBil2-R] derivative is considered in relation to the Hammett value () for each biladiene's R-group. More broadly, the results reported in this study clearly demonstrate that biladiene redox properties, spectral properties, and photophysics can be perturbed greatly by relatively minor alterations to biladiene structure.
光动力疗法(PDT)是一种有前途的治疗某些癌症的方法,其过程是敏化基态 O 以产生反应性 O。经典的大环四吡咯配体支架,如卟啉和酞菁,已经在其 O 光敏化能力方面进行了详细研究。尽管它们具有引人注目的光物理性质,但由于不利的生物学副作用,这些系统在 PDT 应用中受到限制。相反,钯(Pd[DMBil1])配位的寡四吡咯配体的发展为 PDT 确立了新的候选物,显示出极好的生物相容性。本文介绍了一类新的 2,18-双(芳基炔基)取代的 Pd10,10-二甲基-5,15-双(五氟苯基)-biladiene(Pd[DMBil2-R])配合物的合成、电化学和光物理表征。这些第二代 biladienes 相对于先前表征的 Pd biladiene 支架(Pd[DMBil1])具有扩展的共轭。我们表明,这些新衍生物可以高产率制备,并且芳基炔基附加物的电子性质显著影响 Pd biladiene 的光物理性质。通过安装苯乙炔将 Pd[DMBil1]核心的共轭延伸,导致 biladiene 吸收光谱红移约 75nm 进入光疗窗口(600-900nm),同时保持 Pd biladiene 的稳态光谱 O 敏化特性。安装供电子或吸电子基团改变芳基炔基的电子性质,显著影响所得 Pd[DMBil2-R]系列配合物的稳态光谱和光物理性质。最富电子的变体(Pd[DMBil2-N(CH3)2])可以吸收远至 700nm 的光,但敏化 O 形成的能力显著降低。相比之下,带有吸电子官能团的 Pd[DMBil2-R]衍生物(Pd[DMBil2-CN]和 Pd[DMBil2-CF3])显示出超过 90%的 O 量子产率。我们报告的结果表明,来自更富电子的芳基-炔基附加物到缺电子的 biladiene 核心的激发态电荷转移绕过三重态敏化。考虑到每个 biladiene 的 R 基团的哈米特值(),每个 Pd[DMBil2-R]衍生物的光谱和氧化还原性质以及三重态敏化效率。更广泛地说,本研究报告的结果清楚地表明,biladiene 氧化还原性质、光谱性质和光物理性质可以通过对 biladiene 结构的微小改变而大大改变。